BTK
Drug & target - TTD
NameType of TargetSynonymsDiseaseDrugsInhibitorAntibody
Tyrosine-protein kinase BTKSuccessful targetBruton's tyrosine kinase;BPK;Agammaglobulinaemia tyrosine kinase;ATK;B cell progenitor kinaseAcute lymphoblastic leukaemia;B-cell immunodeficiencyAVL-292;AVL-292;AVL-292;AVL-292;AVL-292;AVL-292;Ibrutinib companion diagnostic;ACP-319;CC-292;ACP-196;Ibrutinib;Ibrutinib;Ibrutinib;ONO-4059Ibrutinib companion diagnostic;ACP-319;GDC-0834;compound 38;Inositol 1,3,4,5-Tetrakisphosphate;ACP-196;compound 2c;compound 31;PCI-45292;RN486;Ibrutinib;CGI-1316;LFM-A13
Drug & target - KPID
CNumberInhibitorTargetCASInChI KeyPubChem CID
203LFM-A13BTK62004-35-7UVSVTDVJQAJIFG-VURMDHGXSA-N54676905
211PCI-32765 (Ibrutinib)Btk936563-96-1XYFPWWZEPKGCCK-GOSISDBHSA-N24821094
Drug & target - GRAC
Bruton tyrosine kinase enzyme 629 Tec family 1948 Xq21.33-q22